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Abstract
Background: A critical choice facing breast cancer patients is which surgical treatment –
mastectomy or breast conserving surgery (BCS) – is most appropriate. Several studies have
investigated factors that impact the type of surgery chosen, identifying features such as place of
residence, age at diagnosis, tumor size, socio-economic and racial/ethnic elements as relevant. Such
assessment of "propensity" is important in understanding issues such as a reported under-utilisation
of BCS among women for whom such treatment was not contraindicated. Using Western
Australian (WA) data, we further examine the factors associated with the type of surgical
treatment for breast cancer using a classification tree approach. This approach deals naturally with
complicated interactions between factors, and so allows flexible and interpretable models for
treatment choice to be built that add to the current understanding of this complex decision
process.
Methods: Data was extracted from the WA Cancer Registry on women diagnosed with breast
cancer in WA from 1990 to 2000. Subjects' treatment preferences were predicted from covariates
using both classification trees and logistic regression.
Results: Tumor size was the primary determinant of patient choice, subjects with tumors smaller
than 20 mm in diameter preferring BCS. For subjects with tumors greater than 20 mm in diameter
factors such as patient age, nodal status, and tumor histology become relevant as predictors of
patient choice.
Conclusion: Classification trees perform as well as logistic regression for predicting patient
choice, but are much easier to interpret for clinical use. The selected tree can inform clinicians'
advice to patients.
Background
Breast cancer is a disease that affects about ten percent of
Australian women. Because of its devastating impact on
the community, much research has been conducted on
multiple aspects of the condition, including possible caus-
ative factors, methods of treatment and patient care, and
preventative measures such as breast screening. In this
paper we investigate factors that affect the choice between
the treatment options of mastectomy and breast conserv-
ing surgery (BCS) for Western Australian breast cancer
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of early breast cancer recommend that women be treated
using a multidisciplinary approach involving appropriate
surgery, radiotherapy, and systematic adjuvant therapy
[1,2]. The factors investigated include tumor size and his-
tology, nodal status, martial status, aboriginality, age,
method of payment, area of residence, and country of
birth.
A number of studies have investigated the factors that
determine the type of surgery that breast cancer patients
choose [3-9]. These studies have identified a number of
important factors including place of residence, age at diag-
nosis, tumor size, socio-economic factors, and racial/eth-
nic factors. Studies of this nature are important because
even though there has been an increase in the use of BCS
since the early 1990s, an apparent under-utilisation of
BCS among women for whom such treatment was not
contraindicated has been documented [10]. For this rea-
son, research that may shed light on reasons for the under-
utilisation of BCS is important. For example, if it is found
that women of a certain ethnicity are less likely to choose
BCS when it is a viable option, education campaigns
could be specifically implemented to target these women.
A recent Western Australian study found several factors
that affected the likelihood of women with breast cancer
receiving BCS [7]. In particular, they found that women
from disadvantaged backgrounds were significantly less
likely to receive BCS than those from more privileged
backgrounds. In this study, the classification of an indi-
vidual to a background category was based on a five cate-
gory index of relative social disadvantage, with
disadvantaged backgrounds and privileged backgrounds
at opposite ends of this scale. However, the findings from
this study were criticized because the study failed to adjust
for tumor size [11]. In his criticism, Furnival stated that as
a consequence of tumor size not being included in the
analyses that "no reliable conclusions can be drawn as to
the cause of the lower incidence of breast-conserving sur-
gery in women from 'disadvantaged backgrounds"'. In our
paper we also use data from Western Australia but address
the issue raised by Furnival by including tumor size in our
analyses. In addition, we employ classification trees to
help elucidate the factors as well as the interaction
between factors that are relevant predictors of the choice
of surgery. Classification trees are gaining broader accept-
ance in this area of biomedical research, but they are not
yet in widespread use. Our paper highlights how they can
be used to improve and clarify the results obtained from
the standard logistic regression approach. Classification
trees enable a flow-chart to be produced that can be easily
followed for a patient with a given set of characteristics in
order to predict the likely treatment chosen by the patient.
This property enables classification trees, unlike logistic
regression models, to be readily interpreted by people
with little statistical knowledge. Attempting to explain
treatment decisions based on a set of patient characteris-
tics has been termed the "propensity score method" in the
literature. Graf (1997) provides an application of this
method to the treatment decision of mastectomy versus
BCS [12].
Methods
Data for the study was sourced from linked administrative
data obtained from the Western Australian (WA) Depart-
ment of Health Record Linkage unit. The dataset was
extracted from the WA Linked Database, a dynamic link-
age system linking three core data sources: the WA Cancer
Registry (WACR), the WA Hospital Morbidity Database
(WAHMD) and the WA Death Register. The WAHMD con-
tains comprehensive patient demographic, diagnosis and
procedure information for each hospital admission occur-
ring in any WA hospital. The dataset used consists of the
linked hospital, death and WACR records containing the
diagnosis, subsequent admissions to hospital and death
(where applicable) of 2713 women diagnosed with one
primary breast tumor in WA between 1 January, 1990 and
31 December, 1999. The WA Linked Database is unique in
the Australian context and is an extraordinarily rich and
comprehensive resource [13].
In this analysis, treatment was defined as the last surgical
treatment within four months (120 days) of diagnosis.
The date of diagnosis is defined for this study as the time
at which the subject enters the study as recorded on the
WACR as none of the databases linked by the Western
Australian unit specifies diagnosis date. It is common for
people who initially choose BCS to be readmitted for mas-
tectomy because initial surgery reveals that the cancer is
more progressed than initially advised. Thus, if a subject
had a lumpectomy but was later readmitted for a mastec-
tomy within 120 days of diagnosis, their treatment would
be defined for this study as mastectomy. Individuals who
had no surgery within 120 days following diagnosis were
removed from the dataset. The treatment (surgery) varia-
ble was assigned as follows: a value of 0 was assigned to
those subjects who received mastectomy as surgical treat-
ment for the breast cancer within 120 days as indicated on
the WACR; a value of 1 was assigned to those subjects who
received BCS as the last surgical treatment for the breast
cancer within 120 days as indicated on the WACR.
The explanatory variables included in the analysis were
tumor size (diameter at greatest extent measured in milli-
metres), nodal status (the number of lymph nodes to
which the cancer had spread), tumor histology (ductal,
lobular, or other, for example, tubular), age of the subject
in years, area of residence (metropolitan, rural or remote),
the subject's country of birth, marital status, whether orPage 2 of 8
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method of payment (private or public). Table 1 contains
summary information for each of these variables. The
extracted data constituted 2713 patients. Patients with
tumors of size greater than 100 millimetres in diameter
were removed from the study. This was done to avoid
these patients having an undue influence on the analysis
and because there is a possibility that some of the largest
recorded tumor sizes were the result of recording errors.
Moreover, an important consideration is that patients
with very large tumors (e.g. > 100 mm) may not even be
candidates for breast-conserving surgery. There were a
total of 16 patients with recorded tumor sizes greater than
100 millimetres.
Classification trees and multivariate logistic regression
were used to investigate whether the variables described in
the previous paragraph affected the likelihood of a breast
cancer patient choosing BCS as their treatment. Multivar-
iate logistic regression has been used in a number of stud-
ies of this nature and will be not be described further here.
Classification trees are another, less pervasive, method
that can be used to discriminate for a categorical response
based on several, possibly interacting covariates [14,15].
In this context, classification trees create subgroups of the
data with the property that within the subgroups the out-
comes (choice of BCS or mastectomy) are as homogenous
as possible, and between subgroups the outcomes are het-
erogeneous. These subgroups are created by a recursive
series of rules or binary splits. For example, if we were
only interested in how tumor size and area of residence
were related to choice of surgery a classification tree might
first split on "tumor size smaller than 20 mm", and then
for such tumor sizes it might further split on "area of resi-
dence metropolitan". A classification tree of this form
would be interpreted as follows: a patient with a tumor
size exceeding 20 mm would be predicted to choose mas-
tectomy; a patient with tumor size less than 20 mm and
having a metropolitan area of residence would be pre-
dicted to choose BCS; and a patient with tumor size less
than 20 mm and a rural or remote area of residence would
be predicted to choose mastectomy. This tree has stratified
the population of breast cancer patients into strata of
treatment choice based on tumor size and area of resi-
dence. This simple example illustrates the high interpreta-
bility of classification trees and highlights the reason why
tree representations are popular with medical scientists
and doctors [15].
One potential problem with classification trees is that if
continuos variables are used the tree may select "odd"
splits for these variables; see, for example, Altman et al.
(1994) [16]. For example, a tree model may choose to
split on the continuous variables size and age at a tumor
size of 27.4 mm and at an age of 61.6 years, highly specific
values that are objectively meaningless. One way of avoid-
ing this problem is to a priori select a few sensible splits for
the continuous variables of interest. This was the
approach taken in this study. Patient age and nodal status
were split into three categories ≤ 40,40–60,≥ 60 years and
Table 1: Summary statistics for subject characteristics, N = 2713. For categorical variables, the percentages of subjects in each 
category are presented. For continuous variables, five-number summaries are presented.
Surgery Aboriginality Marital Status
Mastectomy 39.0% No 99.2% Married/De-facto 70.8%
Breast-Conserving Surgery 61.0% Yes 0.8% Otherwise 29.2%
Method of Payment Country of Birth Area of Residence
Public, eligible for Medicare 49.4% Australia 61.1% Metropolitan 78.8%
Private, not insured 3.3% Western Europe 28.2% Rural 15.6%
Private, insured 45.8 % Other 10.8% Remote 5.6%
Ineligible for assistance 1.5%
Tumor Histology Tumor Size (diameter in mm) Patient Age (years)
Ductal 79.7% Minimum 1 mm Minimum 19 yrs
Lobular 12.1% 1st Quartile 12 mm 1st Quartile 47 yrs
Other (mixed/tubular/etc.) 8.1% Median 18 mm Median 56 yrs
3rd Quartile 25 mm 3rd Quartile 65 yrs
Maximum 100 mm Maximum 95 yrs
Nodal Staging Characteristics Tumor Size Categories (T1/2/3) Patient Age Categories
Node negative (N-) 58.8% T1 (20 mm or less) 63.3% Age under 40 8.2%
Node positive (N+) 1 to 3 nodes 26.9% T2 (20 to 50 mm) 33.3% Age 40 to 60 51.8%
Node positive (N+) 4 plus nodes 14.3% T3 (exceeding 50 mm) 3.5% Age 60 or over 40.0%Page 3 of 8
(page number not for citation purposes)
BMC Cancer 2006, 6:98 http://www.biomedcentral.com/1471-2407/6/980,1–3,> 3 nodes, respectively, splits that have been used in
previous studies [17-19]. Tumor size was split into the
three size categories consistent with the American Joint
Committee on Cancer and the International Union
Against Cancer TNM staging system: ≤ 20 mm (T1), 20–
50 mm (T2), ≥ 50 mm (T3). Creating these categorical var-
iables out of the three continuous variables ensures that
the tree can only split at sensible cutpoints, that is, at
points recognised as clinically important by the medical
profession. For ease of comparison, these new categorical
variables were also used in the logistic regression analysis.
While such a choice inherently involves information loss,
the practical loss of information is slight, especially con-
sidering the increased interpretability of the resultant
models.
The classification trees in this paper were fit using the rpart
package available in the statistical package S-Plus [20].
The tree-fitting process initially proceeds by finding the
covariate that "best" divides the subjects into two groups.
The "best" split is defined as the one that results in most
homogeneous subgroups with respect to the response var-
iable, homogeneity assessed with respect to standard
measures of goodness-of-fit such as the drop in deviance
or the misclassification rate at each potential split. The
process then partitions the subjects into the two resulting
groups and repeats the splitting process in each of the two
groups, a process referred to as recursive partitioning. The
tree is "grown" in this way until some minimum group
size is reached. This initial tree is usually too large and
complicated to lead to useful inferences in the same way
as an initial logistic regression fit often contains too many
variables, many of them ultimately insignificant. The ini-
tial, full tree is then "pruned" to produce a simpler, more
interpretable tree that adequately models patient choice
of surgical treatment, compared with the full tree which
likely overfits the data. Pruning a classification tree is the
name given to the process of simplifying the initial tree by
removing some of the lower splits. The pruning used in
this paper was based on minimizing the cross-validated
misclassification error across competing sub-trees. The
minimum group size used and further details on the prun-
ing process used are described below. After a suitable
pruned tree is identified, a process called "burling" (exam-
ining alternative splits at each node in the tree) is used to
assess the reliability of the selected tree.
Results
An initial logistic regression model was fit to assess the
relationship between surgical treatment choice and the
covariates used in this study. The initial model included
only main effects, and the results are presented in Table 2.
The model fit indicated that tumor size was, by far, the
most significant variable in the model, with subjects with
Table 2: Initial logistic regression model fit. Significant variables are denoted by ** (significant at 5%) or *** (significant at 1%).
Term Coefficient Standard Error t-value Significance (1% or 5%)
Intercept -0.471 0.162 -2.905 ***
Tumor Size T1 (baseline)
Tumor Size T2 -0.500 0.045 -11.017 ***
Tumor Size T3 -0.378 0.083 -4.576 ***
Subject Age under 40 (baseline)
Subject Age 40–60 -0.044 0.080 -0.547
Subject Age ≥ 60 -0.144 0.035 -4.058 ***
Area of Residence – Metro (baseline)
Area of Residence – Rural -0.210 0.058 -3.610 ***
Area of Residence – Remote -0.101 0.062 -1.638
Tumor Histology – Ductal (baseline)
Tumor Histology – Lobular -0.151 0.064 -2.343 **
Tumor Histology – Other 0.175 0.056 3.112 ***
Lymph Node Negative (N-) (baseline)
Lymph Node Positive, 1–3 nodes -0.216 0.049 -4.416 ***
Lymph Node Negative, 4 or more nodes -0.189 0.041 -4.625 ***
Country of birth – Australia/NZ (baseline)
Country of birth – Western Europe 0.039 0.050 0.797
Country of birth – Other -0.046 0.046 -1.011
Payment class – Public/Medicare (baseline)
Payment class – Private, not insured 0.045 0.122 0.366
Payment class – Private, insured 0.024 0.046 0.518
Payment class – Ineligible -0.153 0.088 -1.735
Marital Status – Married/De-Factor (baseline)
Marital Status – Other 0.028 0.048 0.578Page 4 of 8
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than subjects with T1 sized tumors. Other significant var-
iables included nodal status (subjects with nodal involve-
ment choosing mastectomy more often than subjects with
no nodal involvement), histology (subjects with lobular
tumors choosing mastectomy more often than subjects
with ductal tumors and subjects with "other" (mixed duc-
tal/lobular, tubular, etc.) tumors choosing BCS more
often than subjects with ductal tumors), area of residence
(rural-based subjects choosing mastectomy more often
than metropolitan-based subjects), and subject age (sub-
jects 60 years and over choosing mastectomy more often
than subjects aged under 60 years). The predicted impor-
tance of tumor size agrees with current clinical practice
guidelines that recommend that BCS only be used for peo-
ple with early stage breast cancer, where a cosmetically
agreeable result is possible. For large tumors in certain
areas of the breast a cosmetically agreeable result is typi-
cally not possible.
Of course, the initial model fit ignored potential interac-
tions between variables in the model. A stepwise proce-
dure was used to fit a larger logistic regression model that
included relevant two-way interactions terms. The results
of that model revealed that several interaction terms were,
indeed, significant, including interactions between size
Classification tree for choice of surgical treatment for breast cancer based on the Western Australian databaseFigure 1
Classification tree for choice of surgical treatment for breast cancer based on the Western Australian database. In the figure, M 
denotes mastectomy, BCS breast-conserving surgery. Terminal nodes in the tree are represented using rectangular boxes, 
while non-terminal nodes are presented as ellipses. At each node, the treatment preferred by the majority of subjects at that 
node is printed within the node along with a numerical breakdown of how many subjects chose each treatment. For example, 
a node with the notation "BCS" and "365/504" means that, of the 869 subjects within that sub-group, the majority (504) chose 
BCS while the remaining 365 chose mastectomy.
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age and tumor histology, age and marital status, and area
of residence and country of birth. The large number of sig-
nificant two-way interactions in the fitted model makes
presentation of results, as well as their subsequent inter-
pretation rather difficult. The presence of numerous sig-
nificant interactions not only makes interpretation of the
model coefficients difficult, it also renders the model use-
less as a basis for forming clinical guidelines for women
faced with the choice between mastectomy and BCS.
In our tree analysis, we initially selected a tree whose size
was based on the results of repeated cross-validation, and
we critically evaluated our initial choice by "burling" the
tree, a process that examines alternative splitting rules at
each node and assesses the performance of these alterna-
ROC curves for the fitted tree (solid line) and logistic regression (dotted line) modelsFigure 2
ROC curves for the fitted tree (solid line) and logistic regression (dotted line) models.
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tree, we imposed a condition that all terminal nodes had
to contain a minimum of 20 subjects. The results of our
tree analysis show that tumor size is, by far, the greatest
determinant of type of surgical treatment for breast cancer
patients. Subjects with small tumors tend to choose BCS
regardless of other factors, while, subjects with moderate
to large tumors appear to behave differentially depending
on a number of other factors. Notably, subjects with mod-
erate to large tumors aged 60 years or over, or aged under
60 years with nodal involvement, or aged under 60 years
with no nodal involvement but a lobular tumor tend to
choose mastectomy. Correspondingly, subjects with mod-
erate to large tumors aged under 60 years with no nodal
involvement and ductal or other type tumor tend to
choose BCS. Individually each relevant factor has a rea-
sonably straightforward biological explanation relating it
to type of surgical treatment, but it should be noted that
the tree model yields conditional rather than unqualified
information about the characteristics of subjects choosing
the respective treatments. For example, factors such as
nodal status, subject age or tumor histology do not appear
to be critical factors in the choice for women with small
tumors; rather, these factors become critical given informa-
tion about tumor size. One of the benefits of tree models is
their ability to communicate such conditional informa-
tion simply, whereas logistic regression models simply
label variables, including complex interaction terms, as
either significant or not without providing information as
to the structure of key conditional relationships more use-
ful in a diagnostic context. The selected tree model is
depicted in Figure 1.
As a further comparison of the logistic and tree
approaches to this analysis we produced an ROC curve for
each model. The resulting curves are depicted in Figure 2.
Based on these curves it appears the two models perform
broadly competitively. The marginally better performance
of the logistic model owes mainly to the fact that the
selected logistic model has considerably more parameters
than the selected tree model. However, these extra param-
eters mean that the slightly better performance of the
logistic model from a sensitivity/specificity prospective
comes at the expense of a loss of interpretability. Given
the relative sizes of the tree model and the selected logistic
regression model, the performance of the tree model is
particularly good.
Discussion
One of the benefits of tree models is that the output – a
simple decision tree – is analogous to a diagnostic process
with which medical professionals are familiar. As a result,
the output of the tree model is generally easy to under-
stand and summarize, even in the presence of significant
two-way or even three-way interactions. This feature of
trees allows the building of simple "profiles" of subjects
who are predicted to prefer BCS over mastectomy and
vice-versa. For example, patients with small tumors are
likely to have BCS as their surgical treatment, while
patients who have moderate to large sized tumors and are
aged 60 years or older are likely to have mastectomy. Note
that profiles of this kind derived from the tree are indica-
tive rather than prescriptive, and that they describe ten-
dencies, or broad patterns, rather than the behavior of
particular individuals. Nevertheless, they are useful in
characterising the patterns of patient behavior observed in
the WACR data set, and in clarifying how the main factors
identified in the analysis combine to influence patients'
choices of surgical treatment for breast cancer. Tumor size
is clearly the factor that dominates a patient's decision
process, although a number of other factors appear rele-
vant for patients with moderate to large sized tumors. The
profiles paint rich but subtle pictures of patient behavior,
indicating that patient decisions are often highly condi-
tional rather than set by separate, individual rules for each
relevant factor. This revelation would come as no surprise
to doctors, as such a nested decision process would be
entirely familiar to them in the context of advising their
patients as to their most appropriate treatment option tak-
ing into account the patient's particular circumstances.
As with any analysis of complex data such as these, our
tree analysis has limitations which must be acknowledged
[15,21]. Firstly, tree models have a tendency to be quite
variable or unstable, wherein a small change in the data
can result in a quite different series of splits and hence a
different tree model. This instability of tree models can
make their interpretation somewhat open to question.
While this problem is inherent to tree models, it is likely
that the tree model produced in this paper is very stable at
the first split on tumor size. The choice of this split was
unequivocal as the improvement in goodness-of-fit (both
from drop in deviance and misclassification standpoints)
from splitting on size at this point was substantially larger
than for any of the other explanatory variables. Neverthe-
less, the interpretation of splits low in the tree structure is
somewhat more uncertain as alternative splits low in the
tree may have produced a tree model with similar good-
ness-of-fit to that of the selected model. Secondly, due to
the large number of statistical comparisons that are per-
formed during the fitting of a tree, p-values are not partic-
ularly useful or interpretable for these models. This issue
necessitates the use of cross-validation or the use of an
independent data set to validate the tree model. A cross-
validatory exploration revealed the selected tree model to
be relatively stable, particularly so with regard to the first
few splits. Thirdly, trees may not capture global linear
relationships between the response and covariates
because the tree must approximate linear effects with a
series of binary splits [14]. These limitations illustrate thatPage 7 of 8
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interactions characteristic of tree models compared to
logistic regression models comes at some cost. It is impor-
tant that these limitations be kept in mind when deciding
whether classification trees are useful as an alternative to
logistic regression in a study of this nature. Further, limi-
tations imposed by the data must also be acknowledged.
While data on tumor size was available, other relevant fac-
tors such as the size of the tumor relative to the size of
breast and the degree of differentiation of the tumor were
not available from this linked database.
Despite these limitations, our analysis offers some clear
advantages over traditional approaches to analysing data
such as these, and our findings are broadly useful for dis-
covering which characteristics impact patients' choice of
surgical treatment for breast cancer, and in estimating the
extent to which each characteristic is important in the
decision-making process.
Conclusion
Classification trees perform as well as logistic regression as
a predictor of patient choice, but are much easier to inter-
pret for clinical use. The selected tree can inform clini-
cians' advice to patients, as well as to clarify complex
interactions between covariates in predicting patient
choice. In the context of this study of breast cancer in
Western Australian patients, the tree model shows that
tumor size is a major determinant of which surgical treat-
ment patients choose, but that a variety of other factors,
such as patient age, nodal status, and tumor histology, are
also important in refining predictions of patient choice.
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